The clinical studies of sildenafil for the ageing male

International Journal of Andrology

Volumn 25, Issue 1, 2002, Pages 28-33

  Tsujimura, Akira ^a   Yamanaka, Masaki ^a   Takahashi, Toru ^a   Miura, Hidenobu ^a   Nishimura, Kenji ^a   Koga, Minoru ^b   Iwasa, Atsushi ^c   Takeyama, Masami ^b   Matsumiya, Kiyomi ^a   Takahara, Shiro ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Higashi Osaka City Central Hospital   (Japan)

^c Iwasa Clinic   (Japan)

Author keywords

Ageing male; Diabetes; Hormonal factor; Sildenafil

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; SILDENAFIL; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; FOLLITROPIN BLOOD LEVEL; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADULT; AGE DISTRIBUTION; AGED; FOLLICLE STIMULATING HORMONE; HUMANS; IMPOTENCE; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PENIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROLACTIN; TESTOSTERONE;

EID: 0036166961     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2605.2002.00320.x     Document Type: Article

References (32)

1. Endocrine screening in 1022 men with erectile dysfunction: Clinical significance and cost-effective strategy
2. Erectile dysfunction in general medicine practice: Prevalence and clinical correlates
3. Prevalence and significance of tobacco smoking in impotence
4. Leydig cell function in normal men: Effect of age, life style, residence, diet and activity
5. Impotence and its medical and physical correlates: Results of the Massachusetts Male Aging Study
6. Effectiveness of treatment for impotence in diabetic men
7. Oral sildenafil in the treatment of erectile dysfunction
8. Possible hypothalamic impotence. Male counterpart to hypothalamic amenorrhea?
9. Is there an andropause, the analogue to menopause, and if so what tissue are affected and how?
10. The influence of blood flow and blood pressure on penile erection
11. Prevalence of self-reported erectile dysfunction in people with long-term IDDM
12. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy
13. Secondary hypogonadism in older man: Its relation to impotence
14. Hyperprolactinemia and impotence: Why, when and how to investigate
15. Drug therapy: Erectile dysfunction
16. Age-related prevalence of erectile dysfunction in Japan: Assessment by the international index of erectile function
17. Clinical safety of oral sildenafil citrate (VIAGRA™) in the treatment of erectile dysfunction
18. Why aged men become impotent
19. Decreased bioavailable testosterone in ageing normal and impotent men
20. The importance of hyperprolactinemia in impotence
21. NIH consensus development panel on impotence
22. Sildenafil: Study of a novel oral treatment for erectile dysfunction in diabetic men
23. Sildenafil for treatment of erectile dysfunction in men with diabetes
24. Ciagarette smoking: An independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence
25. Healthy ageing and male sexual function
26. The relationship between pituitary-gonadal function and sexual behaviour in healthy ageing men
27. Oral therapy of erectile dysfunction in the ageing male
28. The influence of ageing on plasma sex hormone in men: The telecom study
29. Andropause and the ageing male
30. Partial androgen deficiency in ageing male (PADAM)
31. Sexual dysfunction in elderly men
32. Sexual adjustment of male alcohoics